218 studies found for:    Open Studies | "Mycobacterium Infections"
Show Display Options
Rank Status Study
21 Not yet recruiting Biologic Basis Of Increased Susceptibility Of Smokers To Pulmonary Infection With Mycobacterium Tuberculosis
Conditions: Tuberculosis;   Chronic Obstructive Pulmonary Disease
Intervention:
22 Recruiting Database of All Patients With Microbiologically Proven Mycobacteria Tuberculosis Infection
Condition: Tuberculosis
Intervention:
23 Recruiting Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers
Condition: Tuberculosis
Intervention: Drug: Rifampicin
24 Recruiting Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65
Condition: Tuberculosis
Interventions: Biological: 5μg/ml ESAT6-CFP10;   Biological: 10μg/ml ESAT6-CFP10;   Biological: BCG;   Biological: placebo
25 Recruiting Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers
Condition: Tuberculosis
Interventions: Drug: Faropenem;   Drug: Amoxicillin/clavulanic acid 500mg/125mg;   Drug: Rifampicin
26 Unknown  Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
Conditions: Latent Tuberculosis Infection;   Tuberculosis Disease
Intervention:
27 Recruiting A Randomized, Placebo Controlled, Partially Blinded Phase II Study to Evaluate Safety, Immunogenicity, and Prevention of Infection With Mycobacterium Tuberculosis of AERAS-404 and BCG Revaccination in Healthy Adolescents (040-404)
Condition: Tuberculosis
Interventions: Biological: AERAS-404;   Drug: Placebo;   Biological: Bacillus Calmette-Guérin (BCG)
28 Not yet recruiting Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana
Conditions: Mansonella Perstans Infection;   Buruli Ulcer;   Tuberculosis;   Co-infection
Intervention: Drug: Doxycycline
29 Not yet recruiting Mycobacterium w in Patients With Severe Sepsis
Condition: Sepsis
Interventions: Biological: Mycobacterium w;   Other: Best standard care
30 Recruiting Bronchiectasis Research Registry
Conditions: Non-CF Bronchiectasis;   Nontuberculosis Mycobacteria (NTM)
Intervention:
31 Recruiting Phenotypic Clinical, and Genetic Characteristics of Patients With Nontuberculosis Mycobacteria
Condition: Nontuberculosis Mycobacterial Lung Disease
Intervention:
32 Recruiting Rituximab for Anti-cytokine Autoantibody-Associated Diseases
Conditions: Anticytokine Autoantibody-Associated Diseases;   Disseminated Non-Tuberculous Mycobacteria;   Chronic Mucocutaneous Candidiasis;   Pulmonary Alveolar Proteinosis (PAP)
Intervention: Drug: Rituximab/Rituxan
33 Recruiting Performance of IGRAs for TB Infection Diagnosis in Elderly
Conditions: Ageing;   Tuberculosis
Intervention: Other: Blood samples
34 Unknown  The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection
Conditions: Rheumatic Disease;   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Tuberculosis
Intervention:
35 Unknown  Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists
Conditions: Rheumatoid Arthritis;   Spondylarthritis;   Tuberculosis
Interventions: Procedure: Quantiferon-TB Gold assay;   Procedure: Tuberculin skin test
36 Recruiting Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Ethambutol;   Drug: Rifampin;   Drug: Azithromycin;   Drug: Pancrelipase
37 Recruiting PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention:
38 Recruiting PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis
Condition: Cystic Fibrosis
Intervention:
39 Not yet recruiting Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: DTG 50 mg;   Drug: EFV 600 mg
40 Recruiting Evaluating Diagnostics for Paediatric Tuberculosis by Blood Culture
Condition: Tuberculosis Infection
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years